DKSH has entered a partnership agreement with Pfizer in Taiwan to support the distribution and market expansion of selected products by Pfizer.
Media release
Taiwan, December 10, 2020 – DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their business in Asia and beyond, will provide distribution and promotional services for chosen drugs by Pfizer including antibiotics, smoking cessation, vaccines and coagulants, in clinics and front door drugstores in Taiwan.
Pfizer has a leading portfolio of products and medicines that support wellness and prevention as well as treatment and cures for diseases across a broad range of therapeutic areas. The recently signed agreement between DKSH Taiwan and Pfizer demonstrates DKSH's commitment to bringing high-quality medicines to the Taiwan market.
Cellina Yeh, Country Manager, Pfizer Taiwan commented: “With DKSH's in-depth expertise and extensive sales and distribution network across all segments of the healthcare industry, we are confident that DKSH will accelerate the growth of our market coverage through an innovative market expansion strategy.”
Wennie Chang, Vice President, Business Unit Healthcare, DKSH Taiwan, said, “We are proud to partner with Pfizer in Taiwan, a company that is committed to health for all. Our dedicated specialists will drive the expansion and increase the accessibility of Pfizer's wide range of products. Together, we will improve the well-being of patients in Taiwan.”
For further information, please contact:
DKSH Taiwan Limited
Stacy Lee
Manager, Branding and Communications
+886 2 8752 7290
stacy.lee@dksh.com
About Pfizer Inc.: Breakthroughs that change patients’ lives
Established in 1849 and headquartered in New York, Pfizer is one of the world’s leading innovative biopharmaceutical companies. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.
Founded in 1962, Pfizer Taiwan is one of the first multi-national pharmaceutical companies established in Taiwan. Pfizer Taiwan has a local manufacturing site in Hsin Chu, producing world class prescription medicine to local and international markets. Over the last 58 years, we at Pfizer Taiwan collaborate with government agencies, health care providers, medical associations, patient groups, and local communities etc. to provide access to effective, reliable, and affordable healthcare products.
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. The Group helps companies to grow across the Business Units Healthcare, Consumer Goods, Performance Materials and Technology. The service portfolio covers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Publicly listed on the SIX Swiss Exchange, the Group operates in 36 markets with 33,350 specialists, generating net sales of CHF 11.6 billion in 2019. With its Swiss heritage, DKSH has been deeply rooted in Asia Pacific since 1865. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and overt-the-counter (OTC) products as well as medical devices. With around 8,220 specialists, the Business Unit generated net sales of CHF 6.0 billion in 2019.